Intellia Therapeutics, Inc. (NTLA) Discusses Safety Event and Protocol Pause in MAGNITUDE Clinical Trials of Nex-Z Transcript

Core Points - Intellia Therapeutics held a conference call to discuss company updates and investor relations [1] Group 1 - The conference call was initiated by the operator, Jamie, who welcomed participants and noted that the call was being recorded at the company's request [1] - Jason Fredette, Vice President of Investor Relations and Corporate Communications, was introduced to lead the call [1]